Refine Results
  1. "2011"
Formats
  1. Journal Article (2133)
  2. Meeting Abstract (988)
  3. Book Section (135)
  4. Conference Paper (18)
  5. Book Whole (7)
Groups
  1. Surgery (770)
  2. Solid Tumor Oncology Division (652)
  3. Sloan Kettering Institute Faculty (638)
  4. Breast Cancer Disease Management Team (476)
  5. Survivorship Research (438)
  6. Genitourinary Disease Management Team (386)

More Groups

People
  1. Clifford Hudis (58)
  2. Robert Soslow (57)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (46)

More People

Years
  1. 2011 (3281)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (438)
  2. American Society of Clinical Oncology (327)
  3. Nature Publishing Group (244)
  4. American Association for Cancer Research (180)
  5. Springer (179)
  6. Wiley Blackwell (154)

More Publishers

Results (3281)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma
    Meeting Abstract

    Wolchok, J. D.; Thomas, L.; Bondarenko, I. N.; O'Day, S.; Weber, J. S.; Garbe, C.; Francis, S.; Ibrahim, R. A.; Hoos, A.; Robert, C.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Axillary node staging for microinvasive breast cancer: Is it justified?
    Meeting Abstract

    Lyons, J. M.; Stempel, M.; Van Zee, K. J.; Cody, H. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Patient characteristics associated with the decision to undergo bilateral prophylactic mastectomy for lobular carcinoma in situ
    Meeting Abstract

    Muhsen, S.; Junqueira, M. J.; Park, A.; Sung, J. S.; Patil, S.; Oskar, S.; Morrogh, M.; Morrow, M.; King, T. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K. L.; Ulaner, G.; Fazio, M.; Eaton, A.; Patil, S.; Evangelista, L.; Serna-Tamayo, C.; McArthur, H. L.; Hudis, C.; Morris, P. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The novel cytotoxicity of neutrophils in the peripheral blood of breast cancer patients versus women without breast cancer
    Meeting Abstract

    Granot, Z.; Comen, E. A.; Norton, L.; Benezra, R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel
    Meeting Abstract

    Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with (V600E)BRAF-mutated melanoma
    Meeting Abstract

    Chapman, P. B.; Hauschild, A.; Robert, C.; Larkin, J. M. G.; Haanen, J. B. A. G.; Ribas, A.; Hogg, D.; O'Day, S.; Ascierto, P. A.; Testori, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)
    Meeting Abstract

    Aghajanian, C.; Finkler, N. J.; Rutherford, T.; Smith, D. A.; Yi, J.; Parmar, H.; Nycum, L. R.; Sovak, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized double-blind placebo-controlled international trial of abago-vomab maintenance therapy in patients with advanced ovarian cancer after complete response to first-line chemotherapy: The Monoclonal Antibody Immunotherapy for Malignancies of the Ovary by Subcutaneous Abago-vomab (MIMOSA) trial
    Meeting Abstract

    Pfisterer, J.; Berek, J. S.; Casado, A.; Cwiertka, K.; Pinter, T.; Pluzanska, A.; Pujade-Lauraine, E.; Scambia, G.; Vermorken, J. B.; Simonelli, C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC)
    Meeting Abstract

    Kris, M. G.; Johnson, B. E.; Kwiatkowski, D. J.; Iafrate, A. J.; Wistuba, I. I.; Aronson, S. L.; Engelman, J. A.; Shyr, Y.; Khuri, F. R.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save